Rapamycin Guide (2026)
Complete Guide & Evidence (2026)
mTOR inhibitor and the most studied longevity drug. FDA-approved immunosuppressant repurposed at low intermittent doses (2-6mg weekly) for anti-aging via.
mTOR Inhibition: The Core Mechanism
Key Research Findings
Median lifespan increase in NIA ITP mouse studies — even when started at ~65 human-equivalent age.
Most common pulsed weekly dose used in longevity protocols with physician oversight.
Time to peak autophagy upregulation after a single rapamycin dose in animal models.
Pulsed Rapamycin Protocol
Key insight: Pulsed dosing (weekly) achieves mTOR inhibition with far less immunosuppression than daily dosing. GFJ (grapefruit juice) co-ingestion can potentiate absorption 2–3×. Always use under physician supervision with regular bloodwork.
Rapamycin Research Timeline
FDA approved sirolimus (rapamycin) for kidney transplant rejection prevention.
NIA ITP study: rapamycin extends lifespan in mice even when started late in life.
Human studies in healthy elderly: rapamycin improves immune response to flu vaccine.
PEARL trial (2024–2026) studying rapamycin safety/efficacy for healthy aging in humans.
Vital Protocol FAQs
Guide FAQs
mTOR inhibitor and the most studied longevity drug. FDA-approved immunosuppressant repurposed at low intermittent doses (2-6mg weekly) for anti-aging via.
Yes. Shotlee supports tracking Rapamycin doses, side effects, and health metrics. It is free to use.
Track Your Rapamycin Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.